Journalbeiträge 1. Anders S, Strobel L, Krampe H, Raupach T (2013) [Do final-year medical students know enough about the treatment of alcohol use disorders and smoking?]. DEUT MED WOCHENSCHR, 138(1-2): 23-7. 2. Anders S, Kunz M, Gehl A, Sehner S, Raupach T, Beck-Bornholdt HP (2013) Estimation of the time since death--reconsidering the re-establishment of rigor mortis. INT J LEGAL MED, 127(1): 127-30. 3. Andreas S, Hasenfuss G (2013) Beneficial effects of angiotensin receptor blockade in chronic obstructive pulmonary disease. AM J RESP CRIT CARE, 187(3): 328. 4. Bettencourt N, Chiribiri A, Schuster A, Ferreira N, Sampaio F, Duarte R, Santos L, Melica B, Rodrigues A, Braga P, Teixeira M, Simões L, Leite-Moreira A, Silva-Cardoso J, Nagel E, Portugal P, Gama V (2013) Cardiac magnetic resonance myocardial perfusion imaging for detection of functionally significant obstructive coronary artery disease: a prospective study. INT J CARDIOL, 168(2): 765-73. 5. Bettencourt N, Chiribiri A, Schuster A, Ferreira N, Sampaio F, Pires-Morais G, Santos L, Melica B, Rodrigues A, Braga P, Azevedo L, Teixeira M, Leite-Moreira A, Silva-Cardoso J, Nagel E, Gama V (2013) Direct comparison of cardiac magnetic resonance and multidetector computed tomography stress-rest perfusion imaging for detection of coronary artery disease. J AM COLL CARDIOL, 61(10): 1099-107. 6. Bettencourt N, Ferreira N, Chiribiri A, Schuster A, Sampaio F, Santos L, Melica B, Rodrigues A, Braga P, Teixeira M, Leite-Moreira A, Silva-Cardoso J, Portugal P, Gama V, Nagel E (2013) Additive value of magnetic resonance coronary angiography in a comprehensive cardiac magnetic resonance stress-rest protocol for detection of functionally significant coronary artery disease: a pilot study. CIRC-CARDIOVASC IMAG, 6(5): 730-8. 7. Bettencourt N, Ferreira ND, Leite D, Carvalho M, Ferreira WdS, Schuster A, Chiribiri A, Leite-Moreira A, Silva-Cardoso J, Nagel E, Gama V (2013) CAD detection in patients with intermediate-high pre-test probability: low-dose CT delayed enhancement detects ischemic myocardial scar with moderate accuracy but does not improve performance of a stress-rest CT perfusion protocol. JACC-CARDIOVASC IMAG, 6(10): 1062-71. 8. Bigalke B, Phinikaridou A, Andia ME, Cooper MS, Schuster A, Schönberger T, Griessinger CM, Wurster T, Onthank D, Ungerer M, Gawaz M, Nagel E, Botnar RM (2013) Positron emission tomography/computed tomographic and magnetic resonance imaging in a murine model of progressive atherosclerosis using (64)Cu-labeled glycoprotein VI-Fc. CIRC-CARDIOVASC IMAG, 6(6): 957-64. 9. Binder L, Schwörer H, Hoppe S, Streit F, Neumann S, Beckmann A, Wachter R, Oellerich M, Walson PD (2013) Pharmacokinetics of meropenem in critically ill patients with severe infections. THER DRUG MONIT, 35(1): 63-70. 10. Boekstegers P, Hausleiter J, Baldus S, Bardeleben RS, Beucher H, Butter C, Franzen O, Hoffmann R, Ince H, Kuck KH, Rudolph V, Schäfer U, Schillinger W, Wunderlich N (2013) Interventionelle Behandlung der Mitralklappeninsuffizienz mit dem MitraClip-Verfahren. Der Kardiologe, 7: 91-104. 11. Boldt J, Leber AW, Bonaventura K, Sohns C, Stula M, Huppertz A, Haverkamp W, Dorenkamp M (2013) Cost-effectiveness of cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary artery disease in Germany. J CARDIOVASC MAGN R, 15: 30. 12. Brown J, Michie S, Raupach T, West R (2013) Prevalence and characteristics of smokers interested in internet-based smoking cessation interventions: cross-sectional findings from a national household survey. J MED INTERNET RES, 15(3): e50. 13. Chiribiri A, Hautvast GLTF, Lockie T, Schuster A, Bigalke B, Olivotti L, Redwood SR, Breeuwer M, Plein S, Nagel E (2013) Assessment of coronary artery stenosis severity and location: quantitative analysis of transmural perfusion gradients by high-resolution MRI versus FFR. JACC-CARDIOVASC IMAG, 6(5): 600-9. 14. Chuykin I, Schulz H, Guan K, Bader M (2013) PTHRP/Adenylate cyclase promotes parietal whereas Wnt/βcatenin signaling promotes visceral endoderm differentiation of rat XEN cells. J CELL SCI, 126(1): 128-38. 15. Couto A, Oda S, Nikolaev VO, Soltesz Z, de Bono M (2013) In vivo genetic dissection of O2-evoked cgmp dynamics in a Caenorhabditis elegans gas sensor. P NATL ACAD SCI USA, 110(35): E3301-10. 16. Cyganek L, Chens S, Borchert T, Guan K (2013) Cardiac progenitor cells and their therapeutic application for cardiac repair. J Clin Exp Cardiolog, S11:008: 1-12. 17. Czepluch FS, Kuschicke H, Dellas C, Riggert J, Hasenfuss G, Schäfer K (2013) Atheroprotective Krüppellike factor 4 is downregulated in monocyte subsets of patients with coronary artery disease. THROMB HAEMOSTASIS, 110(5): 1080-2. 18. Czepluch FS, Bernhardt M, Kuschicke H, Gogiraju R, Schroeter MR, Riggert J, Hasenfuss G, Schäfer K (2013) In vitro and in vivo effects of human monocytes and their subsets on new vessel formation. MICROCIRCULATION, x: x. Stand:17.02.2015 Seite 1 von 8
19. Czepluch FS, Schlegel M, Bremmer F, Behnes CL, Hasenfuss G, Schäfer K (2013) Stage-dependent detection of CD14+ and CD16+ cells in the human heart after myocardial infarction. VIRCHOWS ARCH, 463(3): 459-69. 20. de Boer RA, Edelmann F, Cohen-Solal A, Mamas MA, Maisel A, Pieske B (2013) Galectin-3 in heart failure with preserved ejection fraction. EUR J HEART FAIL, 15(10): 1095-101. 21. Dellas C, Lankeit M, Reiner C, Schäfer K, Hasenfuß G, Konstantinides S (2013) BMI-independent inverse relationship of plasma leptin levels with outcome in patients with acute pulmonary embolism. INT J OBESITY, 37(2): 204-10. 22. Didié M, Christalla P, Rubart M, Muppala V, Döker S, Unsöld B, El-Armouche A, Rau T, Eschenhagen T, Schwoerer AP, Ehmke H, Schumacher U, Fuchs S, Lange C, Becker A, Tao W, Scherschel JA, Soonpaa MH, Yang T, Lin Q, Zenke M, Han DW, Schöler HR, Rudolph C, Steinemann D, Schlegelberger B, Kattman S, Witty A, Keller G, Field LJ, Zimmermann WH (2013) Parthenogenetic stem cells for tissue-engineered heart repair. J CLIN INVEST, 123(3): 1285-98. 23. Dissmann R, Wolthoff U, Zabel M (2013) Double left ventricular pacing following accidental malpositioning of the right ventricular electrode during implantation of a cardiac resynchronization therapy device. J CARDIOTHORAC SURG, 8(1): 162. 24. Dorenkamp M, Morguet AJ, Sticherling C, Behrens S, Zabel M (2013) Long-term prognostic value of restitution slope in patients with ischemic and dilated cardiomyopathies. PLOS ONE, 8: e54768. 25. Dorenkamp M, Boldt J, Leber AW, Sohns C, Roser M, Boldt LH, Haverkamp W, Bonaventura K (2013) Cost-effectiveness of Paclitaxel-coated balloon angioplasty in patients with drug-eluting stent restenosis. CLIN CARDIOL, 36(7): 407-13. 26. Dorenkamp M, Bonaventura K, Leber AW, Boldt J, Sohns C, Boldt LH, Haverkamp W, Frei U, Roser M (2013) Potential lifetime cost-effectiveness of catheter-based renal sympathetic denervation in patients with resistant hypertension. EUR HEART J, 34(6): 451-61. 27. Dorenkamp M, Sohns C, Vollmann D, Lüthje L, Seegers J, Wachter R, Puls M, Staab W, Lotz J, Zabel M (2013) Detection of left atrial thrombus during routine diagnostic work-up prior to pulmonary vein isolation for atrial fibrillation: role of transesophageal echocardiography and multidetector computed tomography. INT J CARDIOL, 163(1): 26-33. 28. Dudek J, Cheng IF, Balleininger M, Vaz FM, Streckfuss-Bömeke K, Hübscher D, Vukotic M, Wanders RJA, Rehling P, Guan K (2013) Cardiolipin deficiency affects respiratory chain function and organization in an induced pluripotent stem cell model of Barth syndrome. STEM CELL RES, 11(2): 806-19. 29. Edelmann F, Pieske B (2013) [Exercise training in heart failure]. HERZ, 38(6): 578-86. 30. Edelmann F, Gelbrich G, Duvinage A, Stahrenberg R, Behrens A, Prettin C, Kraigher-Krainer E, Schmidt AG, Düngen HD, Kamke W, Tschöpe C, Herrmann-Lingen C, Halle M, Hasenfuss G, Wachter R, Pieske B (2013) Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction - results of the Aldo-DHF trial. INT J CARDIOL, 169(6): 408-17. 31. Edelmann F, Wachter R, Pieske B (2013) Aldosterone inhibition in patients with heart failure with preserved ejection fraction--reply. JAMA-J AM MED ASSOC, 310(2): 205-7. 32. Edelmann F, Wachter R, Schmidt AG, Kraigher-Krainer E, Colantonio C, Kamke W, Duvinage A, Stahrenberg R, Durstewitz K, Löffler M, Düngen HD, Tschöpe C, Herrmann-Lingen C, Halle M, Hasenfuss G, Gelbrich G, Pieske B, Aldo-DHF Investigators (2013) Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. JAMA-J AM MED ASSOC, 309(8): 781-91. 33. Fischer HF, Klug C, Roeper K, Blozik E, Edelmann F, Eisele M, Störk S, Wachter R, Scherer M, Rose M, Herrmann-Lingen C (2013) Screening for mental disorders in heart failure patients using computer-adaptive tests. QUAL LIFE RES, x: x. 34. Fischer TH, Herting J, Tirilomis T, Renner A, Neef S, Toischer K, Ellenberger D, Förster A, Schmitto JD, Gummert J, Schöndube FA, Hasenfuss G, Maier LS, Sossalla S (2013) Ca2+/calmodulin-dependent protein kinase II and protein kinase A differentially regulate sarcoplasmic reticulum Ca2+ leak in human cardiac pathology. CIRCULATION, 128(9): 970-81. 35. Fischer TH, Maier LS, Sossalla S (2013) The ryanodine receptor leak: how a tattered receptor plunges the failing heart into crisis. HEART FAIL REV, 18(4): 475-83. 36. Fischer TH, Neef S, Maier LS (2013) The Ca-calmodulin dependent kinase II: a promising target for future antiarrhythmic therapies? J MOL CELL CARDIOL, 58: 182-7. 37. Friehs I, Illigens B, Melnychenko I, Zhong-Hu T, Zeisberg E, Del Nido PJ (2013) An animal model of endocardial fibroelastosis. J SURG RES, 182(1): 94-100. 38. Götz KR, Nikolaev VO (2013) Advances and techniques to measure cgmp in intact cardiomyocytes. Methods Mol Biol, 1020: 121-9. 39. Grond M, Jauss M, Hamann G, Stark E, Veltkamp R, Nabavi D, Horn M, Weimar C, Köhrmann M, Wachter R, Rosin L, Kirchhof P (2013) Improved Detection of Silent Atrial Fibrillation Using 72-Hour Holter ECG in Patients With Ischemic Stroke: A Prospective Multicenter Cohort Study. STROKE, 44(12): 3357-64. Stand:17.02.2015 Seite 2 von 8
40. Groot AJ, Cobzaru C, Weber S, Saftig P, Blobel CP, Kopan R, Vooijs M, Franzke CW (2013) Epidermal ADAM17 is dispensable for notch activation. J INVEST DERMATOL, 133(9): 2286-8. 41. Gröschel K, Röther J, Laufs U, Wachter R (2013) Herz oder Hirn? Problempatienten an der Schnittstelle zwischen Kardiologie und Neurologie. HERZ, 38: 395-401. 42. Gröschel K, Röther J, Laufs U, Wachter R, Für die Arbeitsgemeinschaft Herz & Hirn der Deutschen Schlaganfall-Gesellschaft und der Deutschen Gesellschaft für Kardiologie Herz- und Kreislaufforschung e. V (2013) [Heart or brain? Problem patients at the interface between cardiology and neurology]. HERZ, 38(4): 395-401; quiz 402-3. 43. Guan K, Hasenfuss G (2013) Cardiac resident progenitor cells: evidence and functional significance. EUR HEART J, 34(36): 2784-7. 44. Hamdani N, Krysiak J, Kreusser MM, Neef S, Dos Remedios CG, Maier LS, Krüger M, Backs J, Linke WA (2013) Crucial role for Ca2(+)/calmodulin-dependent protein kinase-ii in regulating diastolic stress of normal and failing hearts via titin phosphorylation. CIRC RES, 112(4): 664-74. 45. Hasenfuß G, Heusch G (2013) Special issue "Novel perspectives on heart failure". BASIC RES CARDIOL, 108(4): 355. 46. Hasenfuß G, Anker S, Bauersachs J, Böhm M, Hoppe UC, Pieske B, von Scheidt W, Wachter R (2013) Kommentar zu den Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zur Diagnostik und Behandlung der akuten und chronischen Herzinsuffizienz. Der Kardiologe, 7: 105-114. 47. Hasenfuß G, Edelmann F, Wachter R (2013) [Erratum to: Recommendations for the treatment of heart failure. What's new?]. INTERNIST, 54(12): 1522. 48. Hasenfuß G, Edelmann F, Wachter R (2013) [Recommendations for the treatment of heart failure : What's new?]. INTERNIST, 54(9): 1141-51. 49. Jacobshagen C (2013) [Late sodium current and calcium overload--pathogenesis and adequate treatment]. DEUT MED WOCHENSCHR, 138(16): 842-7. 50. Jacobshagen C, Maier LS (2013) [Pathophysiology of chronic myocardial ischemia]. HERZ, 38(4): 329-33. 51. Kensah G, Roa Lara A, Dahlmann J, Zweigerdt R, Schwanke K, Hegermann J, Skvorc D, Gawol A, Azizian A, Wagner S, Maier LS, Krause A, Dräger G, Ochs M, Haverich A, Gruh I, Martin U (2013) Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro. EUR HEART J, 34(15): 1134-46. 52. Kohl T, Lehnart SE (2013) Imaging T-tubules: dynamic membrane structures for deep functions. CARDIOVASC RES, 98(2): 162-4. 53. Kohl T, Westphal V, Hell SW, Lehnart SE (2013) Superresolution microscopy in heart - cardiac nanoscopy. J MOL CELL CARDIOL, 58: 13-21. 54. Krampe H, Strobel L, Beard E, Anders S, West R, Raupach T (2013) German medical students' beliefs about how best to treat alcohol use disorder. EUR ADDICT RES, 19(5): 245-51. 55. Kutty S, Padiyath A, Li L, Peng Q, Rangamani S, Schuster A, Danford DA (2013) Functional maturation of left and right atrial systolic and diastolic performance in infants, children, and adolescents. J AM SOC ECHOCARDIOG, 26(4): 398-409.e2. 56. Lankeit M, Dellas C, Benz V, Hasenfuß G, Konstantinides S (2013) The predictive value of heart-type fatty acid-binding protein is independent from symptom duration in normotensive patients with pulmonary embolism. THROMB RES, 132(5): 543-7. 57. Lankeit M, Friesen D, Schäfer K, Hasenfuß G, Konstantinides S, Dellas C (2013) A simple score for rapid risk assessment of non-high-risk pulmonary embolism. CLIN RES CARDIOL, 102(1): 73-80. 58. Leavesley SJ, L Britain A, Cichon LK, Nikolaev VO, Rich TC (2013) Assessing FRET using spectral techniques. CYTOM PART A, 83(10): 898-912. 59. Lehnart, Stephan E (2013) Understanding the physiology of heart failure through cellular and in vivo models-towards targeting of complex mechanisms. EXP PHYSIOL, 98(3): 622-8. 60. Leifheit-Nestler M, Wagner NM, Gogiraju R, Didié M, Konstantinides S, Hasenfuss G, Schäfer K (2013) Importance of leptin signaling and signal transducer and activator of transcription-3 activation in mediating the cardiac hypertrophy associated with obesity. J TRANSL MED, 11: 170. 61. Lickfett L, Mittmann-Braun E, Weiss C, Spencker S, Jung W, Haverkamp W, Willems S, Deneke T, Kautzner J, Wiedemann M, Siebels J, Pitschner HF, Hoffmann E, Hindricks G, Zabel M, Vester E, Schwacke H, Leyen JV, Mewis C, Bauer W, Lewalter T (2013) Differences in clinical and echocardiographic parameters between paroxysmal and persistent atrial flutter in the AURUM 8 study: targets for prevention of persistent arrhythmia? PACE, 36(2): 194-202. 62. Lowther KM, Uliasz TF, Götz KR, Nikolaev VO, Mehlmann LM (2013) Regulation of Constitutive GPR3 Signaling and Surface Localization by GRK2 and β-arrestin-2 Overexpression in HEK293 Cells. PLOS ONE, 8(6): e65365. 63. Luo M, Guan X, Luczak ED, Lang D, Kutschke W, Gao Z, Yang J, Glynn P, Sossalla S, Swaminathan PD, Weiss RM, Yang B, Rokita AG, Maier LS, Efimov IR, Hund TJ, Anderson ME (2013) Diabetes increases mortality after myocardial infarction by oxidizing CaMKII. J CLIN INVEST, 123(3): 1262-74. Stand:17.02.2015 Seite 3 von 8
64. Maier LS, Sossalla S (2013) The late Na current as a therapeutic target: where are we? J MOL CELL CARDIOL, 61: 44-50. 65. Maier LS, Darius H, Giannitsis E, Erbel R, Haude M, Hamm C, Hasenfuss G, Heusch G, Mudra H, Münzel T, Schmitt C, Schumacher B, Senges J, Voigtländer T, Schüttert JB (2013) The German CPU Registry: comparison of troponin positive to troponin negative patients. INT J CARDIOL, 168(2): 1651-3. 66. Maier LS, Layug B, Karwatowska-Prokopczuk E, Belardinelli L, Lee S, Sander J, Lang C, Wachter R, Edelmann F, Hasenfuss G, Jacobshagen C (2013) RAnoLazIne for the Treatment of Diastolic Heart Failure in Patients With Preserved Ejection Fraction: The RALI-DHF Proof-of-Concept Study. JACC Heart Fail, 1(2): 115-22. 67. Maisano F, Franzen O, Baldus S, Schäfer U, Hausleiter J, Butter C, Ussia GP, Sievert H, Richardt G, Widder JD, Moccetti T, Schillinger W (2013) Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J AM COLL CARDIOL, 62(12): 1052-61. 68. Mayer F, Stahrenberg R, Gröschel K, Mostardt S, Biermann J, Edelmann F, Liman J, Wasem J, Goehler A, Wachter R, Neumann A (2013) Cost-effectiveness of 7-day-Holter monitoring alone or in combination with transthoracic echocardiography in patients with cerebral ischemia. CLIN RES CARDIOL, 102(12): 875-84. 69. Mehel H, Emons J, Vettel C, Wittköpper K, Seppelt D, Dewenter M, Lutz S, Sossalla S, Maier LS, Lechêne P, Leroy J, Lefebvre F, Varin A, Eschenhagen T, Nattel S, Dobrev D, Zimmermann WH, Nikolaev VO, Vandecasteele G, Fischmeister R, El-Armouche A (2013) Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes. J AM COLL CARDIOL, 62(17): 1596-606. 70. Menke J, Unterberg-Buchwald C, Staab W, Sohns JM, Seif Amir Hosseini A, Schwarz A (2013) Head-tohead comparison of prospectively triggered vs retrospectively gated coronary computed tomography angiography: Meta-analysis of diagnostic accuracy, image quality, and radiation dose. AM HEART J, 165(2): 154-63.e3. 71. Mischke K, Knackstedt C, Marx N, Vollmann D (2013) Insights into atrial fibrillation. MINERVA MED, 104(2): 119-30. 72. Neef S, Maier LS (2013) Novel aspects of excitation-contraction coupling in heart failure. BASIC RES CARDIOL, 108(4): 360. 73. Neef S, Sag CM, Daut M, Bäumer H, Grefe C, El-Armouche A, DeSantiago J, Pereira L, Bers DM, Backs J, Maier LS (2013) While systolic cardiomyocyte function is preserved, diastolic myocyte function and recovery from acidosis are impaired in CaMKIIδ-KO mice. J MOL CELL CARDIOL, 59: 107-16. 74. Nickenig G, Mohr FW, Kelm M, Kuck KH, Boekstegers P, Hausleiter J, Schillinger W, Brachmann J, Lange R, Reichenspurner H (2013) Konsensus der Deutschen Gesellschaft für Kardiologie Herz- und Kreislaufforschung und der Deutschen Gesellschaft für Thorax-, Herz- und Gefäßchirurgie zur Behandlung der Mitralklappeninsuffizienz. Der Kardiologe, 7: 76-90. 75. Otton J, Morton G, Schuster A, Bigalke B, Marano R, Olivotti L, Nagel E, Chiribiri A (2013) A direct comparison of the sensitivity of CT and MR cardiac perfusion using a myocardial perfusion phantom. J Cardiovasc Comput Tomogr, 7(2): 117-24. 76. Papait R, Cattaneo P, Kunderfranco P, Greco C, Carullo P, Guffanti A, Viganò V, Stirparo GG, Latronico MVG, Hasenfuss G, Chen J, Condorelli G (2013) Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy. P NATL ACAD SCI USA, 110(50): 20164-9. 77. Pereira E, Bettencourt N, Ferreira N, Schuster A, Chiribiri A, Primo J, Teixeira M, Simões L, Leite-Moreira A, Silva-Cardoso J, Gama V, Nagel E (2013) Incremental value of adenosine stress cardiac magnetic resonance in coronary artery disease detection. INT J CARDIOL, 168(4): 4160-7. 78. Perera RK, Nikolaev VO (2013) Compartmentation of camp signalling in cardiomyocytes in health and disease. ACTA PHYSIOL, 207(4): 650-62. 79. Puls M, Eiffert H, Hünlich M, Schöndube F, Hasenfuß G, Seipelt R, Schillinger W (2013) Prosthetic valve endocarditis after transcatheter aortic valve implantation: the incidence in a single-centre cohort and reflections on clinical, echocardiographic and prognostic features. EUROINTERVENTION, 8(12): 1407-18. 80. Puls M, Seipelt R, Schillinger W (2013) Complete interventional heart repair of multiple concomitant cardiac pathologies in a staged approach. CATHETER CARDIO INTE, 81(5): 896-900. 81. Puls M, Tichelbäcker T, Bleckmann A, Hünlich M, von der Ehe K, Beuthner BE, Rüter K, Beißbarth T, Seipelt R, Schöndube F, Hasenfuß G, Schillinger W (2013) Failure of acute procedural success predicts adverse outcome after percutaneous edge-to-edge mitral valve repair with MitraClip. EUROINTERVENTION, x: x. 82. Purohit A, Rokita AG, Guan X, Chen B, Koval OM, Voigt N, Neef S, Sowa T, Gao Z, Luczak ED, Stefansdottir H, Behunin AC, Li N, El-Accaoui RN, Yang B, Swaminathan PD, Weiss RM, Wehrens XHT, Song LS, Dobrev D, Maier LS, Anderson ME (2013) Oxidized Ca(2+)/calmodulin-dependent protein kinase II triggers atrial fibrillation. CIRCULATION, 128(16): 1748-57. Stand:17.02.2015 Seite 4 von 8
83. Rainer PP, Primessnig U, Harenkamp S, Doleschal B, Wallner M, Fauler G, Stojakovic T, Wachter R, Yates A, Groschner K, Trauner M, Pieske BM, von Lewinski D (2013) Bile acids induce arrhythmias in human atrial myocardium--implications for altered serum bile acid composition in patients with atrial fibrillation. HEART, 99(22): 1685-92. 84. Rasenack ECL, Oehler M, Elsässer A, Schilling M, Maier LS (2013) Evaluation of a novel portable capacitive ECG system in the clinical practice for a fast and simple ECG assessment in patients presenting with chest pain: FIDET (Fast Infarction Diagnosis ECG Trial). CLIN RES CARDIOL, 102(3): 179-84. 85. Raupach T, Brown J, Anders S, Hasenfuss G, Harendza S (2013) Summative assessments are more powerful drivers of student learning than resource intensive teaching formats. BMC MED, 11: 61. 86. Raupach T, Brown J, Wieland A, Anders S, Harendza S (2013) Should we pay the student? A randomised trial of financial incentives in medical education. MED TEACH, 35(9): 760-6. 87. Raupach T, Strobel L, Beard E, Krampe H, Anders S, West R (2013) German medical students' beliefs about the effectiveness of different methods of stopping smoking. NICOTINE TOB RES, 15(11): 1892-901. 88. Raupach T, Vogel D, Schiekirka S, Keijsers C, Ten Cate O, Harendza S (2013) Increase in medical knowledge during the final year of undergraduate medical education in Germany. Gms Z Med Ausbild, 30(3): Doc33. 89. Raupach T, West R, Brown J (2013) The most "successful" method for failing to quit smoking is unassisted cessation. NICOTINE TOB RES, 15(3): 748-9. 90. Reichenspurner H, Schillinger W, Baldus S, Hausleiter J, Butter C, Schäefer U, Pedrazzini G, Maisano F, ACCESS-EU Phase I Investigators (2013) Clinical outcomes through 12 months in patients with degenerative mitral regurgitation treated with the MitraClip device in the ACCESS-EUrope Phase I trial. EUR J CARDIO-THORAC, 44(4): e280-8. 91. Romppel M, Herrmann-Lingen C, Wachter R, Edelmann F, Düngen HD, Pieske B, Grande G (2013) A short form of the General Self-Efficacy Scale (GSE-6): Development, psychometric properties and validity in an intercultural non-clinical sample and a sample of patients at risk for heart failure. Psychosoc Med, 10: Doc01. 92. Rüter K, Puls M, von der Ehe K, Tichelbäcker T, Sobisiak B, Beuthner BE, Hünlich M, Schillinger W (2013) Preclosure of femoral vein access site with the suture-mediated Proglide device during MitraClip implantation. J INVASIVE CARDIOL, 25(10): 508-10. 93. Sag CM, Wagner S, Maier LS (2013) Role of oxidants on calcium and sodium movement in healthy and diseased cardiac myocytes. FREE RADICAL BIO MED, 63: 338-49. 94. Sag CM, Wolff HA, Neumann K, Opiela MK, Zhang J, Steuer F, Sowa T, Gupta S, Schirmer M, Hünlich M, Rave-Fränk M, Hess CF, Anderson ME, Shah AM, Christiansen H, Maier LS (2013) Ionizing radiation regulates cardiac Ca handling via increased ROS and activated CaMKII. BASIC RES CARDIOL, 108(6): 385. 95. Schäfer K, Konstantinides S (2013) Mechanisms Linking Leptin to Arterial and Venous Thrombosis: Potential Pharmacological Targets. CURR PHARM DESIGN, x: x. 96. Scharf M, Neef S, Freund R, Geers-Knörr C, Franz-Wachtel M, Brandis A, Krone D, Schneider H, Groos S, Menon MB, Chang KC, Kraft T, Meissner JD, Boheler KR, Maier LS, Gaestel M, Scheibe RJ (2013) Mitogen-activated protein kinase-activated protein kinases 2 and 3 regulate SERCA2a expression and fiber type composition to modulate skeletal muscle and cardiomyocyte function. MOL CELL BIOL, 33(13): 2586-602. 97. Scherer M, Düngen HD, Inkrot S, Tahirović E, Lashki DJ, Apostolović S, Edelmann F, Wachter R, Loncar G, Haverkamp W, Neskovic A, Herrmann-Lingen C (2013) Determinants of change in quality of life in the Cardiac Insufficiency Bisoprolol Study in Elderly (CIBIS-ELD). EUR J INTERN MED, 24(4): 333-8. 98. Schiekirka S, Reinhardt D, Beißbarth T, Anders S, Pukrop T, Raupach T (2013) Estimating learning outcomes from pre- and posttest student self-assessments: a longitudinal study. ACAD MED, 88(3): 369-75. 99. Schillinger W, Hünlich M, Baldus S, Ouarrak T, Boekstegers P, Hink U, Butter C, Bekeredjian R, Plicht B, Sievert H, Schofer J, Senges J, Meinertz T, Hasenfuß G (2013) Acute outcomes after MitraClip therapy in highly aged patients: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) Registry. EUROINTERVENTION, 9(1): 84-90. 100. Schneider HE, Stahl M, Kriebel T, Schillinger W, Schill M, Jakobi J, Paul T (2013) Double cryoenergy application (freeze-thaw-freeze) at growing myocardium: lesion volume and effects on coronary arteries early after energy application. Implications for efficacy and safety in pediatric patients. J Cardiovasc Electrophysiol, 24(6): 701-7. 101. Schroeter MR, Eschholz N, Herzberg S, Jerchel I, Leifheit-Nestler M, Czepluch FS, Chalikias G, Konstantinides S, Schäfer K (2013) Leptin-dependent and leptin-independent paracrine effects of perivascular adipose tissue on neointima formation. ARTERIOSCL THROM VAS, 33(5): 980-7. 102. Schroeter MR, Hasenfuß G, Zabel M, Vollmann D (2013) Atrial standstill in a patient with progressive severe heart failure. CLIN RES CARDIOL, 102(6): 473-6. Stand:17.02.2015 Seite 5 von 8
103. Schroeter MR, Leifheit-Nestler M, Hubert A, Schumann B, Glückermann R, Eschholz N, Krüger N, Lutz S, Hasenfuss G, Konstantinides S, Schäfer K (2013) Leptin promotes neointima formation and smooth muscle cell proliferation via NADPH oxidase activation and signalling in caveolin-rich microdomains. CARDIOVASC RES, 99(3): 555-65. 104. Schroeter MR, Unsöld B, Holke K, Schillinger W (2013) Pro-thrombotic condition in a woman with peripartum cardiomyopathy treated with bromocriptine and an Impella LP 2.5 heart pump. CLIN RES CARDIOL, 102(2): 155-7. 105. Schuster A, Morton G, Hussain ST, Jogiya R, Kutty S, Asrress KN, Makowski MR, Bigalke B, Perera D, Beerbaum P, Nagel E (2013) The intra-observer reproducibility of cardiovascular magnetic resonance myocardial feature tracking strain assessment is independent of field strength. EUR J RADIOL, 82(2): 296-301. 106. Schuster A, Paul M, Bettencourt N, Morton G, Chiribiri A, Ishida M, Hussain S, Jogiya R, Kutty S, Bigalke B, Perera D, Nagel E (2013) Cardiovascular magnetic resonance myocardial feature tracking for quantitative viability assessment in ischemic cardiomyopathy. INT J CARDIOL, 166(2): 413-20. 107. Schwoerer AP, Neef S, Broichhausen I, Jacubeit J, Tiburcy M, Wagner M, Biermann D, Didié M, Vettel C, Maier LS, Zimmermann WH, Carrier L, Eschenhagen T, Volk T, El-Armouche A, Ehmke H (2013) Enhanced Ca²+ influx through cardiac L-type Ca²+ channels maintains the systolic Ca²+ transient in early cardiac atrophy induced by mechanical unloading. PFLUG ARCH EUR J PHY, 465(12): 1763-73. 108. Sohns C, Lüthje L, Zabel M, Vollmann D (2013) Supraventricular tachycardia with 'A-A-V' response upon ventricular entrainment and transient 2:1 AV conduction block. CLIN RES CARDIOL, 102(12): 927-9. 109. Sohns C, Sohns JM, Bergau L, Sossalla S, Vollmann D, Lüthje L, Staab W, Dorenkamp M, Harrison JL, O'Neill MD, Lotz J, Zabel M (2013) Pulmonary vein anatomy predicts freedom from atrial fibrillation using remote magnetic navigation for circumferential pulmonary vein ablation. EUROPACE, 15(8): 1136-42. 110. Sohns C, Sohns JM, Vollmann D, Lüthje L, Bergau L, Dorenkamp M, Zwaka PA, Hasenfuß G, Lotz J, Zabel M (2013) Left atrial volumetry from routine diagnostic work up prior to pulmonary vein ablation is a good predictor of freedom from atrial fibrillation. Eur Heart J Cardiovasc Imaging, 14(7): 684-91. 111. Sohns JM, Staab W, Sohns C, Schwarz A, Streit U, Hosseini ASA, Spiro JE, Kertész A, Zwaka PA, Lotz J (2013) Current perspective of multidetector computed tomography (MDCT) in patients after midface and craniofacial trauma. CLIN IMAG, 37(4): 728-33. 112. Sossalla S, Sohns C, Seegers J, Lüthje L, Vollmann D, Zabel M (2013) Ranolazine maintained sinus rhythm in a patient with refractory symptomatic atrial fibrillation. CARDIOVASC THER, 31(5): 303-6. 113. Sprenger JU, Nikolaev VO (2013) Biophysical Techniques for Detection of camp and cgmp in Living Cells. INT J MOL SCI, 14(4): 8025-46. 114. Stahrenberg R, Niehaus CF, Edelmann F, Mende M, Wohlfahrt J, Wasser K, Seegers J, Hasenfuß G, Gröschel K, Wachter R (2013) High-sensitivity troponin assay improves prediction of cardiovascular risk in patients with cerebral ischaemia. J NEUROL NEUROSUR PS, 84(5): 479-87. 115. Strauchmann J, Wallbach M, Bramlage C, Puls M, Konstantinides S, Mueller GA, Koziolek MJ (2013) Lipoprotein apheresis reduces biomarkers of plaque destabilization and cardiovascular risk. J CLIN APHERESIS, x: x. 116. Streckfuss-Bömeke K, Wolf F, Azizian A, Stauske M, Tiburcy M, Wagner S, Hübscher D, Dressel R, Chen S, Jende J, Wulf G, Lorenz V, Schön MP, Maier LS, Zimmermann WH, Hasenfuss G, Guan K (2013) Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts. EUR HEART J, 34(33): 2618-29. 117. Toischer K, Hartmann N, Wagner S, Fischer TH, Herting J, Danner BC, Sag CM, Hund TJ, Mohler PJ, Belardinelli L, Hasenfuss G, Maier LS, Sossalla S (2013) Role of late sodium current as a potential arrhythmogenic mechanism in the progression of pressure-induced heart disease. J MOL CELL CARDIOL, 61: 111-22. 118. Tziakas D, Chalikias G, Kapelouzou A, Tentes I, Schäfer K, Karayannakos P, Kostakis A, Boudoulas H, Konstantinides S (2013) Erythrocyte membrane cholesterol and lipid core growth in a rabbit model of atherosclerosis: Modulatory effects of rosuvastatin. INT J CARDIOL, 170(2): 173-81. 119. Vanderhoek AJ, Hammal F, Chappell A, Wild TC, Raupach T, Finegan BA (2013) Future physicians and tobacco: An online survey of the habits, beliefs and knowledge base of medical students at a Canadian university. Tob Induc Dis, 11(1): 9. 120. Voelkel T, Andresen C, Unger A, Just S, Rottbauer W, Linke WA (2013) Lysine methyltransferase Smyd2 regulates Hsp90-mediated protection of the sarcomeric titin springs and cardiac function. BICHIM BIOPHYS ACTA, 1833(4): 812-22. 121. Voit D, Zhang S, Unterberg-Buchwald C, Sohns JM, Lotz J, Frahm J (2013) Real-time cardiovascular magnetic resonance at 1.5 T using balanced SSFP and 40 ms resolution. J CARDIOVASC MAGN R, 15: 79. Stand:17.02.2015 Seite 6 von 8
122. Vollmann D, Sossalla S, Schroeter MR, Zabel M (2013) Renal artery ablation instead of pulmonary vein ablation in a hypertensive patient with symptomatic, drug-resistant, persistent atrial fibrillation. CLIN RES CARDIOL, 102(4): 315-8. 123. von Bardeleben RS, Schillinger W (2013) Use of the MitraClip Device in Practice. An update on the European registry experience. Cardiac interventions today, Sept/Oct: 1-6. 124. Wachter R, Lüthje L, Klemmstein D, Lüers C, Stahrenberg R, Edelmann F, Holzendorf V, Hasenfuß G, Andreas S, Pieske B (2013) Impact of obstructive sleep apnoea on diastolic function. EUR RESPIR J, 41(2): 376-83. 125. Wachter R, Stahrenberg R, Gröschel K (2013) Subclinical atrial fibrillation: how hard should we look? HEART, 99(3): 151-3. 126. Wachter R, Weber-Krüger M, Gröschel K (2013) Letter by Wachter et al regarding article, "occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitors". STROKE, 44(9): e111. 127. Wachter R, Weber-Krüger M, Seegers J, Edelmann F, Wohlfahrt J, Wasser K, Gelbrich G, Hasenfuß G, Stahrenberg R, Liman J, Gröschel K (2013) Age-dependent yield of screening for undetected atrial fibrillation in stroke patients: the Find-AF study. J NEUROL, 260(8): 2042-5. 128. Wagner NM, Brandhorst G, Czepluch F, Lankeit M, Eberle C, Herzberg S, Faustin V, Riggert J, Oellerich M, Hasenfuss G, Konstantinides S, Schäfer K (2013) Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk. OBESITY, 21(3): 461-8. 129. Wagner S, Maier LS (2013) Small conductance Ca-activated K channel: small but powerful proarrhythmogenic? HEART RHYTHM, 10(6): 899-900. 130. Wagner S, Rokita AG, Anderson ME, Maier LS (2013) Redox regulation of sodium and calcium handling. ANTIOXID REDOX SIGN, 18(9): 1063-77. 131. Weber-Krüger M, Gröschel K, Mende M, Seegers J, Lahno R, Haase B, Niehaus CF, Edelmann F, Hasenfuß G, Wachter R, Stahrenberg R (2013) Excessive supraventricular ectopic activity is indicative of paroxysmal atrial fibrillation in patients with cerebral ischemia. PLOS ONE, 8(6): e67602. 132. Zabel M, Vollmann D, Lüthje L, Seegers J, Sohns C, Zenker D, Hasenfuss G (2013) Randomized Clinical evaluation of wireless fluid monitoring and remote ICD management using OptiVol alert-based predefined management to reduce cardiac decompensation and health care utilization: the CONNECT- OptiVol study. CONTEMP CLIN TRIALS, 34(1): 109-16. 133. Zeisberg EM, Zeisberg M (2013) The role of promoter hypermethylation in fibroblast activation and fibrogenesis. J PATHOL, 229(2): 264-73. Buchbeiträge 1. Chuykin I, Stauske M, Guan K (2013) Chapter 9 Spermatogonial Stem Cells. In: Gustav Steinhoff (Hg.) Regenerative Medicine. Springer, 219-249. 2. Gebker R, Schuster A, Nagel E (2013) Assessment of Ischemic Heart Disease Utilizing Dobutamine. In: Higgins CB, De Roos A (Hg.) MRI & CT of the Cardiovascular System. Lippincott, Williams & Wilkins Verlag, 239-251. 3. Hünlich M, Puls M, Schillinger W (2013) Severe shunt beside the guide. In: Franzen O, Feldman T, Low R, Rogers J, Yeo KK (Hg.) Procedural Guide and Atlas. Springer, 457-460. 4. Jacobshagen C (2013) Abgrenzung der stabilen Myokardischämie zum akuten Koronarsyndrom. In: Maier L (Hg.) Der ischämische Patient. UNI-MED Verlag, 40-44. 5. Lüthje L, Vollmann D (2013) Notfälle bei Patienten mit implantiertem Schrittmacher oder Defibrillator. In: Eckardt, Forst, Briegel (Hg.) Intensivmedizin. Ecomed Verlag, Heidelberg, 1-23. 6. Puls M, HÜnlich M, Schillinger W (2013) MitraClip implantation in chronic degenerative mitral regurgitation with extensive calcification. In: Franzen O, Feldman T, Low R, Rogers J, Yeo KK (Hg.) MitraClip Therapy: Procedural Guide and Atlas. Springer, 461-470. 7. Raupach T (2013) Vaccination against nicotine to facilitate smoking cessation. In: Polosa R, Caponnetto P. (Hg.) Advances in Smoking Cessation. Future Medicine Ltd, London, 68-72. 8. Raupach T, Schiekirka S (2013) Innovationen im Medizinstudium. In: Berendt B, Fleischmann A, Schaper N, Szczyrba B, Wildt J (Hg.) Neues Handbuch Hochschullehre. Raabe Verlag, Stuttgart, 1-26. 9. Sossalla S (2013) Die ischämische Herzmuskelzelle. Bedeutung der Kalziumüberladung und des späten Natriumeinstroms (INa,late). In: Maier LS (Hg.) Der ischämische Patient. UNI-MED Verlag, 32-36. 10. Zarinabad N, Chiribiri A, Hautvast GTF, Schuster A, Sinclair M, Wijngaard JHM, Smith N, Spaan JE, Siebes M, Breeuwer M, Nagel E (2013) Modelling parameter role on accuracy of cardiac perfusion quantification. In: Ourselin Sb, Rueckert D, Smith N (Hg.) Functional imaging and modeling of the heart. Springer, 370-382. Stand:17.02.2015 Seite 7 von 8
Habilitationen 1. Hünlich M (2013) Die Bedeutung von Proteinzusammensetzung und Phosphorylierungsstatus des Aktin- Myosin-Komplexes bei Herzinsuffizienz und Vorhofflimmern. Habilitation Universität Göttingen. 2. Schroeter M (2013) Mechanismen von Läsionen und Wundheilung im Gefäßsystem und deren Beeinflussung durch kardiovaskuläre Risikofaktoren - Bedeutung des Adipozytenhormons Leptin. Habilitation Universität Göttingen. 3. Stahrenberg R (2013) Die Find-AF Studie - Optimierte Detektion von paroxysmalem Vorhofflimmern und neue Biomarker zur Prognoseabschätzung bei Patienten mit cerebraler Ischämie. Habilitation Universität Göttingen. Medizinische Dissertationen 1. Bäumer H, Dr. med. (2013) Die Bedeutung der δ -Isoform der Kalzium-Calmodulin-abhängigen Proteinkinase II (CaMKII) für die Azidose bei isolierten Kardiomyozyten. Dissertation Universität Göttingen. 2. Bellmann S, Dr. med. (2013) Die Bedeutung der Ca2+/Calmodulin-abhängigen Kinase IIδ für sauerstoffradikalvermittelte zytosolische Natrium- und Kalziumüberladung sowie Arrhythmogenese in Herzmuskelzellen. Dissertation Universität Göttingen. 3. Böcker C, Dr. med. (2013) Posttranskriptionale Veränderungen der E3-Ubiquitin-Ligase IMP (impedes mitogenic signal propagation). Dissertation Universität Göttingen. 4. Christians C, Dr. med. (2013) Die Genregulation des myokardialen Na+/ca2+-Austauschers. Dissertation Universität Göttingen. 5. Daut M, Dr. med. (2013) Funktionelle Charakterisierung der Kalzium/Calmodulin-abhängigen Proteinkinase II- (CaMKII )-Knockout-Maus. Dissertation Universität Göttingen. 6. Gupta SN, Dr. med. (2013) Die Effekte der Ca2+-Calmodulin-abhängigen Proteinkinase II (CaMKII) auf die Aktionspotentialmorphologie bei mechanischer Last. Dissertation Universität Göttingen. 7. Kern M, Dr. med. (2013) Transport- und Behandlungszeiten im Herzinfarktnetz Göttingen - Eine Erhebung über 18 Monate bei Patienten mit ST-Hebungsinfarkt. Dissertation Universität Göttingen. 8. Klarner SF, Dr. med. (2013) Prognostische Bedeutung der Mikroneurographie in Bezug auf Morbidität und Mortalität bei chronisch obstruktiver Lungenerkrankung und Herzinsuffizienz. Dissertation Universität Göttingen. 9. Minkov E, Dr. med. (2013) Reduzierte Variabilität der Herzfrequenz bei Patienten mit Epilepsie bzw. untger antikonvulsiver Medikation. Dissertation Universität Göttingen. 10. Pax AT, Dr. med. (2013) Einfluss milder therapeutischer Hypothermie auf die respiratorische und kardiale Funktion nach primär erfolgreicher kardiopulmonaler Reanimation. Dissertation Universität Göttingen. 11. Schremmer C, Dr. med. (2013) Bedeutung von Urokinase-Plasimogen-Aktivator für das Wachstum und die Stabilität arteriosklerotischer Gefäßläsionen im Apolipprotein-E-Knockout-Mausmodell. Dissertation Universität Göttingen. 12. Schultz G, Dr. med. (2013) Koronare Mikroembolisation am Kaninchenmodell: Simvastatin vermindert die Inflammation und myokardiale Dysfunktion nach koronarer Mikroembolisation. Dissertation Universität Göttingen. 13. Weil MB, Dr. med. (2013) Evaluation eines neuartigen kapazitiven EKG-Systems bei Patienten mit akutem ST-Hebungs-Myokardinfarkt. Dissertation Universität Göttingen. Masterarbeiten 1. Borchert T, MA (2013) Modeling catecholaminergic polymorphic ventricular tachycardia with induced pluripotent stem cells. Masterarbeit Universität Göttingen. 2. Haupt L, MA (2013) Generation and characterization of induced pluripotent stem cells from patients with CPVT. Masterarbeit Universität Göttingen. Stand:17.02.2015 Seite 8 von 8